Market Analysis and Insights: Global Artificial Tears Market

Artificial tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.

Due to the COVID-19 pandemic, the global Artificial Tears market size is estimated to be worth US$ 2921.6 million in 2022 and is forecast to a readjusted size of US$ 5240.1 million by 2029 with a CAGR of 8.6% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Artificial Tear Liquid accounting for % of the Artificial Tears global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Dry Eyes Treatment segment is altered to an % CAGR throughout this forecast period.

The industry's leading producers are Allergan, Alcon and Bausch & Lomb, with revenues of 23.40%, 27.67% and 8.98%, respectively, in 2019.

Global Artificial Tears Scope and Market Size

The global Artificial Tears market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Artificial Tears market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Artificial Tear Liquid

Artificial Tear Ointment


Segment by Application


Dry Eyes Treatment

Contact Lenses Moisten

Others

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Allergan

Alcon

Bausch & Lomb

Johnson & Johnson

Santen Pharmaceutical

Ursapharm

Rohto

Similasan Corporation

Ocusoft

Sintong

Wuhan Yuanda